NCT02161965View on ClinicalTrials.gov

Vascular CalcIfiCation and sTiffness Induced by ORal antIcoAgulation

PHASE4CompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

May 21, 2013

Primary Completion Date

December 31, 2016

Study Completion Date

February 16, 2018

Conditions
Permanent Atrial FibrillationVenous ThrombosisPulmonary EmbolismAnticoagulation Treatment at Least > or = to 12-month
Interventions
DRUG

Rivaroxaban

20mg or 15mg

DRUG

Fluindione

DRUG

Warfarin

Trial Locations (1)

49933

University Hospital Angers, Angers

All Listed Sponsors
lead

University Hospital, Angers

OTHER_GOV

NCT02161965 - Vascular CalcIfiCation and sTiffness Induced by ORal antIcoAgulation | Biotech Hunter | Biotech Hunter